Endovascular Treatment Devices Market to Reach USD 9.7 Billion by 2036, Driven by Rising Cardiovascular Disease Burden and Rapid Technological Advancements

The global Endovascular Treatment Devices Market is poised for strong and sustained growth over the next decade, supported by the rising prevalence of cardiovascular and peripheral vascular diseases and the growing adoption of minimally invasive treatment approaches worldwide. According to industry analysis, the market was valued at US$ 3.7 billion in 2025 and is projected to reach US$ 9.7 billion by 2036, expanding at a robust compound annual growth rate (CAGR) of 9.2% from 2026 to 2036.

Endovascular therapies have emerged as a preferred alternative to traditional open surgeries, offering shorter hospital stays, reduced complications, faster recovery times, and improved patient outcomes. As healthcare systems worldwide continue to prioritize efficiency, safety, and cost-effectiveness, endovascular treatment devices are becoming a cornerstone of modern vascular care.

Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=56028

Market Overview: Endovascular treatment devices are specialized medical instruments designed to treat arterial and venous disorders through minimally invasive procedures. These devices are delivered via catheters and guidewires using advanced imaging technologies, allowing physicians to diagnose and repair vascular abnormalities through small incisions rather than open surgical methods.

They are widely used in the management of conditions such as peripheral artery disease (PAD), aortic aneurysms, thrombosis, coronary artery disease, and neurovascular disorders. Key device categories include stents, stent-grafts, balloon catheters, thrombectomy devices, embolic protection systems, and imaging-guided navigation tools.

The increasing preference for minimally invasive procedures among both patients and clinicians is fundamentally reshaping vascular treatment paradigms and accelerating demand for advanced endovascular solutions.

Key Market Growth Drivers

Rising Prevalence of Cardiovascular and Vascular Diseases

The global rise in cardiovascular and vascular diseases is the most significant driver of the endovascular treatment devices market. Increasing incidences of peripheral artery disease, aortic aneurysms, thrombosis, and coronary artery disease are closely linked to aging populations, sedentary lifestyles, poor dietary habits, and the growing prevalence of diabetes, hypertension, and obesity.

As these conditions often require long-term management and repeated interventions, the demand for minimally invasive, repeatable, and patient-friendly treatment options continues to rise. Endovascular therapies offer reduced trauma, lower complication rates, and faster recovery compared to open surgeries, making them an increasingly attractive option for both physicians and patients.

Technological Advancements in Endovascular Devices

Rapid innovation in endovascular device design and materials is significantly enhancing procedural precision, safety, and efficacy. Advancements include drug-eluting stents, bioresorbable materials, next-generation balloon catheters, advanced stent-grafts, and high-performance thrombectomy devices.
Emerging technologies such as robotics-assisted interventions, artificial intelligence-based imaging guidance, and real-time navigation systems are further expanding the scope of treatable vascular conditions. These innovations not only improve clinical outcomes but also encourage broader adoption of endovascular therapies across hospitals and ambulatory surgical centers.

Segment Analysis: EVAR Devices Leading Market Growth

The Percutaneous Endovascular Aneurysm Repair (EVAR) devices segment accounted for the largest market share in 2025 and continues to be a major growth contributor. EVAR offers a less invasive alternative to open surgical repair of thoracic and abdominal aortic aneurysms by reinforcing weakened sections of the aorta using stent-grafts.

Percutaneous delivery through small groin incisions minimizes surgical trauma, reduces hospital stays, and lowers post-operative complications. As the global population ages and risk factors such as smoking, hypertension, and obesity remain prevalent, the demand for EVAR procedures is expected to rise steadily.
Technological improvements, including customizable stent-grafts and enhanced imaging guidance, are further increasing clinician confidence and patient acceptance, particularly in emerging markets.

Analysis of Key Players

The endovascular treatment devices market is moderately consolidated, with global and regional players focusing on innovation, strategic collaborations, and geographic expansion. Key companies operating in the market include:

• Medtronic plc
• Boston Scientific Corporation
• Terumo Corporation
• Cardinal Health
• Endospan Ltd.
• Lombard Medical
• Boston Scientific
• Abbott Laboratories
• Cook
• W. L. Gore & Associates, Inc.
• Penumbra, Inc.
• Cordis Corporation
• Endospan
• Endologix LLC.
• Other Prominent Players
These players compete on the basis of product portfolio depth, technological differentiation, clinical outcomes, and regulatory approvals.

Key Player Strategies

Market leaders are adopting a range of strategies to strengthen their competitive positions, including:
• Continuous investment in research and development to launch next-generation devices
• Strategic mergers, acquisitions, and partnerships to expand product offerings
• Focus on regulatory approvals and clinical trials to validate safety and efficacy
• Expansion into emerging markets to capture untapped demand
• Development of physician training programs to support adoption of advanced procedures

Buy this Premium Research Report to gain valuable industry intelligence - https://www.transparencymarketresearch.com/checkout.php?rep_id=56028<ype=S

Recent Developments

• In September 2025, Jupiter Endovascular announced that its Vertex catheter received FDA 510(k) clearance for the insertion of endovascular devices. Jupiter's Vertex catheter comprises part of the vertex system designed to treat acute pulmonary embolism (PE). The innovative endovascular procedure offers high levels of control and precision.

• In November 2025, Terumo Aortic announced enrolment of the first patient in the Fenestrated TREO pivotal Investigational Device Exemption (IDE) study in the US.

• In October 2025, Medtronic plc announced that it had received U.S. Food and Drug Administration (FDA) labeling approval for the Medtronic Endurant stent graft system, by adding ruptured abdominal aortic aneurysm (rAAA) clinical evidence and removing the rAAA treatment warning.

Market Challenges and Opportunities

Despite strong growth prospects, the market faces challenges such as high device and procedure costs, limited reimbursement in certain regions, regulatory complexities, and a shortage of highly trained interventional specialists.
However, these challenges are balanced by significant opportunities, particularly in emerging economies where healthcare infrastructure is improving and awareness of minimally invasive vascular treatments is increasing. Ongoing technological innovation and supportive government healthcare initiatives are expected to further unlock market potential.

Investment Landscape and ROI Outlook

The endovascular treatment devices market presents an attractive investment landscape, characterized by strong long-term demand, continuous innovation, and expanding clinical applications. Companies investing in advanced device technologies, AI-enabled navigation systems, and emerging market expansion are well-positioned to achieve favorable returns on investment over the forecast period.

Market Segmentation

By Product Type:
• Percutaneous EVAR Devices
• Fenestrated EVAR Devices
• Self-Expanding Nitinol Stents
• Aortic Stents
• Thoracic Aortic Aneurysm Grafts
• Others

By Procedure Type:
• Balloon Angioplasty
• Angioplasty with Stent Placement
• Drug-Eluting Stent Procedures
• Thrombolysis / Thrombectomy
• Renal Artery Angioplasty and Stenting
• Others

By Application:
• Vascular
• Cardiology
• Neurology
• Others

By End User:
• Hospitals
• Ambulatory Surgical Centers
• Others

By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Why Buy This Report?

• In-depth market sizing and forecasts through 2036
• Comprehensive analysis of drivers, restraints, and opportunities
• Detailed competitive landscape and company profiles
• Strategic insights into emerging technologies and investment trends
• Region- and segment-specific growth analysis

Frequently Asked Questions (FAQs)

1. How big was the global endovascular treatment devices market in 2025?
The market was valued at US$ 3.7 billion in 2025.

2. What is the projected market size by 2036?
The market is expected to reach US$ 9.7 billion by 2036.

3. What factors are driving market growth?
Key drivers include the rising prevalence of cardiovascular and vascular diseases and continuous technological advancements in endovascular devices.

4. What is the expected growth rate during the forecast period?
The market is anticipated to grow at a CAGR of 9.2% from 2026 to 2036.

5. Which region is expected to dominate the market?
North America is expected to maintain the largest market share throughout the forecast period.

Explore Latest Research Reports by Transparency Market Research:

Hypodermic Needles Market: https://www.transparencymarketresearch.com/hypodermic-needles-market.html

Suture Anchors Market: https://www.transparencymarketresearch.com/suture-anchors-market.html

Polymerase Chain Reaction (PCR) Market: https://www.transparencymarketresearch.com/pcr-technologies.html

Embolotherapy Market: https://www.transparencymarketresearch.com/embolotherapy-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.